S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology ( EADV )
Journal of the European Academy of Dermatology and Venereology · 2023-06 · 37 (6) · 1118-1134
DOI: 10.1111/jdv.18931 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 25.03.2023. Verfasst von Emiliano Antiga und 53 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Paraneoplastic Syndromes, Paraneoplastic Syndromes, Nervous System. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Paraneoplastic pemphigus (PNP), also called paraneoplastic autoimmune multiorgan syndrome (PAMS), is a rare autoimmune disease with mucocutaneous and multi‐organ involvement. PNP/PAMS is typically associated with lymphoproliferative or haematological malignancies, and less frequently with solid malignancies. The mortality rate of PNP/PAMS is elevated owing to the increased risk of severe infections and disease‐associated complications, such as bronchiolitis obliterans.
Objectives
These guidelines summarize evidence‐based and expert‐based recommendations (S2k level) for the clinical characterization, diagnosis and management of PNP/PAMS. They have been initiated by the Task Force Autoimmune Blistering Diseases of the European Academy of Dermatology and Venereology with the contribution of physicians from all relevant disciplines. The degree of consent among all task force members was included.
Results
Chronic severe mucositis and polymorphic skin lesions are clue clinical characteristics of PNP/PAMS. A complete assessment of the patient with suspected PNP/PAMS, requiring histopathological study and immunopathological investigations, including direct and indirect immunofluorescence, ELISA and, where available, immunoblotting/immunoprecipitation, is recommended to achieve a diagnosis of PNP/PAMS. Detection of anti‐envoplakin antibodies and/or circulating antibodies binding to the rat bladder epithelium at indirect immunofluorescence is the most specific tool for the diagnosis of PNP/PAMS in a patient with compatible clinical and anamnestic features. Treatment of PNP/PAMS is highly challenging. Systemic steroids up to 1.5 mg/kg/day are recommended as first‐line option. Rituximab is also recommended in patients with PNP/PAMS secondary to lymphoproliferative conditions but might also be considered in cases of PNP/PAMS associated with solid tumours. A multidisciplinary approach involving pneumologists, ophthalmologists and onco‐haematologists is recommended for optimal management of the patients.
Conclusions
These are the first European guidelines for the diagnosis and management of PNP/PAMS. Diagnostic criteria and therapeutic recommendations will require further validation by prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
- Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, Denmark.
- Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Dermatology, Venereology and Allergology, Innsbruck Medical University, Innsbruck, Austria.
- Rare Diseases Unit, Azienda USL Toscana Centro, European Reference Network Skin Member, Florence, Italy.
ORCID-Profile: Emiliano Antiga, Giovanni Genovese, Luca Borradori, Frédéric Caux, Maryam Daneshpazhooh, Dipankar De, Marian Dmochowski, Kossara Drenovska, Claudio Feliciani, Silke C Hofmann, Dimitrios Ioannidis, Khalaf Kridin, Pascal Joly, Emanual Maverakis, Joost Meijer, Aikaterini Patsatsi, Carlo Pincelli, Nina Van Beek, Gang Wang, Mingyue Wang, Takashi Hashimoto, Enno Schmidt, José Manuel Mascarò, Angelo Valerio Marzano
Förderung
- NCI NIH HHS
Zitieren
APA
Antiga, E., Bech, R., Maglie, R., Genovese, G., Borradori, L., Bockle, B., Caproni, M., Caux, F., Chandran, N. S., Corrà, A., D'Amore, F., Daneshpazhooh, M., De, D., Didona, D., Dmochowski, M., Drenovska, K., Ehrchen, J., Feliciani, C., Goebeler, M., …, & Marzano, A. V. (2023). S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology ( EADV ). Journal of the European Academy of Dermatology and Venereology, 37(6), 1118-1134. https://doi.org/10.1111/jdv.18931
Vancouver
Antiga E, Bech R, Maglie R, Genovese G, Borradori L, Bockle B, et al. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology ( EADV ). Journal of the European Academy of Dermatology and Venereology. 2023;37(6):1118-1134. doi:10.1111/jdv.18931
BibTeX
@article{Antiga2023,
author = {Antiga, Emiliano and Bech, Rikke and Maglie, Roberto and Genovese, Giovanni and Borradori, Luca and Bockle, Barbara and Caproni, Marzia and Caux, Frédéric and Chandran, Nisha Suyien and Corrà, Alberto and D'Amore, Francesco and Daneshpazhooh, Maryam and De, Dipankar and Didona, Dario and Dmochowski, Marian and Drenovska, Kossara and Ehrchen, Jan and Feliciani, Claudio and Goebeler, Matthias and Groves, Richard and Günther, Claudia and Handa, Sanjeev and Hofmann, Silke C and Horvath, Barbara and Ioannidis, Dimitrios and Jedlickova, Hana and Kowalewski, Cezary and Kridin, Khalaf and Joly, Pascal and Lim, Yen Loo and Marinovic, Branka and Maverakis, Emanual and Meijer, Joost and Patsatsi, Aikaterini and Pincelli, Carlo and Prost, Catherine and Setterfield, Jane and Sprecher, Eli and Skiljevic, Dusan and Tasanen, Kaisa and Uzun, Soner and Van Beek, Nina and Vassileva, Snejina and Vorobyev, Artem and Vujic, Igor and Wang, Gang and Wang, Mingyue and Wozniak, Katarzyna and Yayli, Savas and Zambruno, Giovanna and Hashimoto, Takashi and Schmidt, Enno and Mascarò, José Manuel and Marzano, Angelo Valerio},
title = {S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology ( EADV )},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
volume = {37},
number = {6},
pages = {1118--1134},
doi = {10.1111/jdv.18931}
}
EUVIMED